Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients

被引:0
|
作者
Mariana Elizondo-Zertuche
Alexandra M. Montoya
Efrén Robledo-Leal
Idalia Garza-Veloz
Ana L. Sánchez-Núñez
Raquel Ballesteros-Elizondo
Gloria M. González
机构
[1] Universidad Autónoma de Nuevo León,Departamento de Microbiología, Facultad de Medicina
[2] Universidad Autónoma de Nuevo León,Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas
[3] Universidad Autónoma de Zacatecas,Laboratorio de Medicina Molecular, Unidad Académica de Medicina Humana y Ciencias de la Salud
[4] Universidad Autónoma de Nuevo León,Departamento de Histología, Facultad de Medicina
来源
Mycopathologia | 2017年 / 182卷
关键词
Pathogenicity; In vitro susceptibility; Survival study; Tissue burden;
D O I
暂无
中图分类号
学科分类号
摘要
We identified 11 Lomentospora prolificans isolates recovered from Mexican patients using phenotypic and molecular characteristics. The identification of isolates was assessed by internal transcribed spacer (ITS rDNA) sequencing. In vitro susceptibility to amphotericin B, fluconazole, voriconazole, posaconazole, caspofungin, anidulafungin and micafungin was determined according to Clinical and Laboratory Standards Institute (CLSI) procedures. Three isolates (07-2239, 11-2242 and 04-2673) were used to induce systemic infection in immunocompetent ICR mice. Survival and tissue burden studies were used as markers of pathogenicity. All of the strains were resistant to every antifungal tested with MIC’s for AmB (8–>8 µg/ml), VRC (16–>16 µg/ml), PSC (16–>16 µg/ml), FLC (64–>64 µg/ml) and echinocandins with MICs ≥8 µg/ml. One hundred, ninety and sixty percent of the infected mice with the strains 07-2239, 11-2242 and 04-2673 died during the study, respectively. Regarding tissue burden, the highest fungal load of the infected mice was detected in brain followed by spleen and kidney, regardless of the strain.
引用
收藏
页码:681 / 689
页数:8
相关论文
共 50 条
  • [21] Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans
    Yaakoub, Hajar
    Staerck, Cindy
    Mina, Sara
    Godon, Charlotte
    Fleury, Maxime
    Bouchara, Jean-Philippe
    Calenda, Alphonse
    VIRULENCE, 2021, 12 (01) : 1076 - 1090
  • [22] In Vitro and In Vivo Effect of the Imidazole Luliconazole against Lomentospora prolificans and Scedosporium spp.
    Furnica, Dan-Tiberiu
    Dittmer, Silke
    Scharmann, Ulrike
    Meis, Jacques F.
    Steinmann, Joerg
    Rath, Peter-Michael
    Kirchhoff, Lisa
    MICROBIOLOGY SPECTRUM, 2023, 11 (03)
  • [23] Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature
    Seidel, Danila
    Hassler, Angela
    Salmanton-Garcia, Jon
    Koehler, Philipp
    Mellinghoff, Sibylle C.
    Carlesse, Fabianne
    Cheng, Matthew P.
    Falces-Romero, Iker
    Herbrecht, Raoul
    Jover Saenz, Alfredo
    Klimko, Nikolai
    Mares, Mihai
    Lass-Floerl, Cornelia
    Soler-Palacin, Pere
    Wisplinghoff, Hilmar
    Cornely, Oliver A.
    Pana, Zoi
    Lehrnbecher, Thomas
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 92 : 114 - 122
  • [24] In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans
    Meletiadis, J
    Mouton, JW
    Rodriguez-Tudela, JL
    Meis, JFGM
    Verweij, PE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 470 - 472
  • [25] Surface properties, adhesion and biofilm formation on different surfaces by Scedosporium spp. and Lomentospora prolificans
    Mello, Thais P.
    Oliveira, Simone S. C.
    Frases, Susana
    Branquinha, Marta H.
    Santos, Andre L. S.
    BIOFOULING, 2018, 34 (07) : 800 - 814
  • [26] Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France
    Vignals, Carole
    Emmerich, Joseph
    Begueret, Hugues
    Garcia-Hermoso, Dea
    Martin-Blondel, Guillaume
    Angoulvant, Adela
    Blez, Damien
    Bruneval, Patrick
    Cassaing, Sophie
    Catherinot, Emilie
    Cahen, Pierre
    Molucon-Chabrot, Cecile
    Chevenet, Carole
    Delhaes, Laurence
    Escaut, Lelia
    Faruch, Marie
    Grenouillet, Frederic
    Larosa, Fabrice
    Limousin, Lucie
    Longchampt, Elisabeth
    Mellot, Francois
    Nourrisson, Celine
    Bougnoux, Marie-Elisabeth
    Lortholary, Olivier
    Roux, Antoine
    Rozenblum, Laura
    Puges, Mathilde
    Lanternier, Fanny
    Bronnimann, Didier
    EMERGING INFECTIOUS DISEASES, 2024, 30 (06) : 1077 - 1087
  • [27] Chemical and immunological characterization of an α-glucan from Scedosporium prolificans
    da Silva, M. I. D.
    Cartagenes-Pinto, A. C.
    Lopes, L. C. L.
    Bittencourt, V. C. B.
    Haido, R. M. T.
    Souza, L. M.
    Barreto-Bergter, E.
    MYCOSES, 2012, 55 : 300 - 300
  • [28] Prognostic factors in 260 adults with invasive Scedosporium spp. and Lomentospora prolificans infections from the literature and FungiScope™
    Seidel, D.
    Meissner, A.
    Lackner, M.
    Piepenbrock, E.
    Salmanton-Garcia, J.
    Mellinghoff, S.
    Hamprecht, A.
    Vehreschild, M. J. G.
    Vehreschild, J.
    Wisplinghoff, H.
    Cornely, A.
    MYCOSES, 2018, 61 : 8 - 8
  • [29] Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates
    Wu, Yongqin
    Grossman, Nina
    Totten, Marissa
    Memon, Warda
    Fitzgerald, Anna
    Ying, Chunmei
    Zhang, Sean X.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [30] Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans
    Mello, Thais P.
    Aor, Ana Carolina
    Goncalves, Diego S.
    Seabra, Sergio H.
    Branquinha, Marta H.
    Santos, Andre L. S.
    BIOFOULING, 2016, 32 (07) : 737 - 749